Business
Research Reports Initiated on Healthcare Stocks Valeant Pharmaceuticals International, Merus Labs International, and Knight Therapeutics
LONDON, UK / ACCESSWIRE / March 9, 2017 / Active Wall St. announces the list of stocks for t...
About this update from Knight Therapeutics, Inc.
[{"type":"text","content":"Research Reports Initiated on Healthcare Stocks Valeant Pharmaceuticals International, Merus Labs International, and Knight TherapeuticsLONDON, UK / ACCESSWIRE / March 9, 2017 / Active Wall St. announces the list of stocks for today's research reports. Pre-market the Active Wall St. team provides the technical coverage impacting selected stocks trading on the Toronto Exchange and belonging under the Drug Manufacturers industry. Companies recently under review include Valeant Pharmaceuticals International, Merus Labs International, and Knight Therapeutics. Get all of our free research reports by signing up at:\n \nhttp://www.activewallst.com/register/ \n \nOn Wednesday, March 08, 2017, at the end of trading session, the Toronto Exchange Composite index ended the day at 15,496.98, 0.72% lower, on a total volume of 396,743,018 shares.\n \nAdditionally, the Healthcare index was slightly up by 0.14%, ending the session at 69.09. \n \nActive Wall St. has initiated research reports on the following equities: Valeant Pharmaceuticals International Inc. (TSX: VRX), Merus Labs International Inc. (TSX: MSL), and Knight Therapeutics Inc. (TSX: GUD). Register with us now for your free membership and research reports at:\nhttp://www.activewallst.com/register/\nValeant Pharmaceuticals International, Inc.\n \nLaval, Canada-based Valeant Pharmaceuticals International Inc.'s stock advanced 2.10%, to finish Wednesday's session at $16.03 with a total volume of 1.41 million shares traded. Shares of the Company, which develops, manufactures, and markets pharmaceuticals, over-the-counter products, and medical devices worldwide, are trading below its 50-day and 200-day moving averages. Valeant Pharma's 200-day moving average of $25.50 is above its 50-day moving average of $19.28. See our research report on VRX.TO at:\nhttp://www.activewallst.com/register/ \nMerus Labs International Inc.\n \nOn Wednesday, shares in Toronto, Canada headquartered Merus Labs International Inc. recorded a trading volume of 216,848 shares. The stock ended the day 5.65% lower at $1.17. Merus Labs International's stock has gained 13.59% in the past one month. Shares of the Company, which owns, markets, and distributes pharmaceutical products primarily in Europe and Canada, are trading above its 50-day moving average. The stock's 200-day moving average of $1.21 is above its 50-d...